BR112018001157A2 - hypertension prophylaxis and cardiovascular disease - Google Patents

hypertension prophylaxis and cardiovascular disease

Info

Publication number
BR112018001157A2
BR112018001157A2 BR112018001157A BR112018001157A BR112018001157A2 BR 112018001157 A2 BR112018001157 A2 BR 112018001157A2 BR 112018001157 A BR112018001157 A BR 112018001157A BR 112018001157 A BR112018001157 A BR 112018001157A BR 112018001157 A2 BR112018001157 A2 BR 112018001157A2
Authority
BR
Brazil
Prior art keywords
cardiovascular disease
prophylaxis
hypertension
hypertension prophylaxis
compound
Prior art date
Application number
BR112018001157A
Other languages
Portuguese (pt)
Inventor
Mace Catherine
Castaneda Gutierrez Euridice
David Taylor Paul
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112018001157A2 publication Critical patent/BR112018001157A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

fórmula 1 a presente invenção refere-se a um composto da fórmula 1, ou um metabólito do mesmo, para uso na profilaxia da hipertensão e/ou de uma doença cardiovascular em uma prole, que compreende a administração do composto a uma grávida e/ou lactante, em que a fêmea tem sobrepeso ou é obesa.Formula 1 The present invention relates to a compound of formula 1, or a metabolite thereof, for use in the prophylaxis of hypertension and / or cardiovascular disease in an offspring comprising administering the compound to a pregnant and / or pregnant woman. in which the female is overweight or obese.

BR112018001157A 2015-09-02 2016-08-26 hypertension prophylaxis and cardiovascular disease BR112018001157A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15183460 2015-09-02
PCT/EP2016/070213 WO2017036971A1 (en) 2015-09-02 2016-08-26 Prophylaxis of hypertension and cardiovascular diseases

Publications (1)

Publication Number Publication Date
BR112018001157A2 true BR112018001157A2 (en) 2018-09-18

Family

ID=54105618

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001157A BR112018001157A2 (en) 2015-09-02 2016-08-26 hypertension prophylaxis and cardiovascular disease

Country Status (7)

Country Link
EP (1) EP3344237A1 (en)
CN (1) CN107921010A (en)
BR (1) BR112018001157A2 (en)
CA (1) CA2994223A1 (en)
MX (1) MX2018002034A (en)
PH (1) PH12018500076A1 (en)
WO (1) WO2017036971A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107648243B (en) * 2017-10-23 2020-02-14 昆药集团股份有限公司 Application of Quzhazhigan in preparation of medicine for treating cerebral hemorrhage or reducing cerebral hemorrhage caused by rtPA thrombolytic therapy after cerebral ischemia
IT201900019325A1 (en) * 2019-10-18 2021-04-18 Ghs Gemelli Health System S R L Mixture comprising fruit extracts, and polyphenols extracted from leaves or fruits of Olea Europaea L. and inulin and use of this composition in the treatment of acute and chronic inflammatory diseases, localized or systemic, or resulting from ischemia or impaired functionality of the vascular endothelium

Also Published As

Publication number Publication date
MX2018002034A (en) 2018-04-13
CA2994223A1 (en) 2017-03-09
CN107921010A (en) 2018-04-17
WO2017036971A1 (en) 2017-03-09
EP3344237A1 (en) 2018-07-11
PH12018500076A1 (en) 2018-07-09

Similar Documents

Publication Publication Date Title
BR112017017217A2 (en) A composition comprising ramnolipid and siloxane.
BR112015021352A2 (en) antimicrobial compositions
BR112018006368A2 (en) composition for improved performance
BR112015029987A8 (en) A2 beta-casein and the prevention of intestinal inflammation
BR112018011216A2 (en) methods to inhibit the conversion of choline to trimethylamine (tma)
BR112015027079A8 (en) aqueous composition, methods for obtaining an antiperspirant benefit, method for making an aqueous antiperspirant composition, antiperspirant salt and use of an antiperspirant composition
MX2016002241A (en) Alkynyl alcohols and methods of use.
BR112016006227A2 (en) passion fruit seed lipid extract
BR112015021254A2 (en) oral formulations of deferasirox
BR112015030385A8 (en) compound, compound for use and pharmaceutical composition
BR112014003640A8 (en) weight loss methods and ketogenic compositions
BR112016013194A2 (en) ORAL HYGIENE COMPOSITIONS COMPRISING CALCIUM CARBONATE AND SILICA
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
BR112016007068A2 (en) ? cosmetic compositions?
BR112017028048A2 (en) drospirenone as the only contraceptive ingredient for use
UY37016A (en) INHIBITORS OF BRUTON TYROSINE KINASE AND METHODS OF USE
BR112017006425A2 (en) isoxazole derivative as mutant isocitrate dehydrogenase 1 inhibitor
BR112016028518A2 (en) pharmaceutical compositions comprising dgla and use thereof
BR112016000612B8 (en) Use of milk in the manufacture of a composition to prevent or reduce symptoms of lactose intolerance
BR112015030774A2 (en) new compounds for cancer treatment
BR112014027738A2 (en) Talole fatty acid that is modified by saponification for use, food supplement, and food compound
BR112015027333A2 (en) aqueous composition, method for obtaining an antiperspirant benefit, method for manufacturing an aqueous antiperspirant composition and use of a
BR112018001157A2 (en) hypertension prophylaxis and cardiovascular disease
BR112017001000A2 (en) sugar compositions for tabletting by direct compression
BR112018076553A2 (en) two-component composition.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07E Notice of approval relating to section 229 industrial property law
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements